Hongmei Yan
5PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 24, 2026
Canagliflozin attenuates CMR-quantified myocardial fibrosis in individuals with type 2 diabetes mellitus at high cardiovascular risk: a randomised open-label controlled trial.Hongmei Yan, Jiaojiao Liu, Zhitian Zhang
|Nov 17, 2023
Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open-label, controlled trial.Yujuan Fan, Mingfeng Xia, Hongmei Yan
|Aug 08, 2022
A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease.Xinyu Yang, Mingfeng Xia, Xinxia Chang
|Jun 17, 2022
Obese Skeletal Muscle-Expressed Interferon Regulatory Factor 4 Transcriptionally Regulates Mitochondrial Branched-Chain Aminotransferase Reprogramming Metabolome.Ting Yao, Hongmei Yan, Xiaopeng Zhu
|Mar 24, 2021
Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease.Xinyu Yang, Xinxia Chang, Shengdi Wu
Pageof 1
